Literature DB >> 7008601

Economic consequences of pelvic inflammatory disease in the United States.

J W Curran.   

Abstract

Pelvic inflammatory disease is the most common serious complication of sexually transmitted infections caused by Neisseria gonorrhoeae and Chlamydia trachomatis. Initial episodes of sexually transmitted acute PID occur most frequently in the 20 to 24 year age group, while sequelae such as infertility, ectopic pregnancy, and chronic PID are most common among 25- to 34-year-old women. The apparent chronicity of the disease process suggests that the epidemic of sexually transmitted disease, which began in the mid-1960s, could be followed by an epidemic of PID and its sequelae. More than 850,000 episodes of PID occur annually, requiring more than 212,000 hospital admissions, 115,000 surgical procedures, and 2,500,000 physician visits. Ectopic pregnancies in the United States tripled from 1967 to 1977. Direct and indirect costs for PID and PID-associated ectopic pregnancy exceeded $1.25 billion in 1979. If PID and ectopic pregnancy rates continue unabated, by the year 2000 there will have been more than one episode of PID and three related physician visits for every two women who reached reproductive age in 1970. Fifteen percent will require hospitalization, more than 3% will experience an ectopic pregnancy, and more than 10% will involuntarily become sterile because of PID.

Entities:  

Mesh:

Year:  1980        PMID: 7008601     DOI: 10.1016/0002-9378(80)91069-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Detection of specific IgG and IgA antibodies to Chlamydia trachomatis in women with salpingitis confirmed by laparoscopy.

Authors:  N G Osborne; Y Hecht; J Gorsline; B A Forbes; F Morgenstern; J Winkelman
Journal:  J Natl Med Assoc       Date:  1989-05       Impact factor: 1.798

2.  A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans.

Authors:  Manli Qi; Siqi Gong; Lei Lei; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

3.  [Not Available].

Authors:  M Steben; J Yelle
Journal:  Can Fam Physician       Date:  1983-05       Impact factor: 3.275

4.  Sexually transmitted diseases and the family physician.

Authors:  M Steben; J Yelle
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

5.  Trends in hospitalization for pelvic inflammatory disease in Canada, 1971-81.

Authors: 
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

Review 6.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

7.  Infection with multiple sexually transmitted agents.

Authors:  N G Osborne; L Grubin
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

8.  Control of sexually transmitted diseases: view from the United States of America.

Authors:  W Cates; W C Parra; S T Brown
Journal:  Br J Vener Dis       Date:  1984-10

9.  Morbidity associated with pelvic inflammatory disease.

Authors:  M W Adler; E H Belsey; B H O'Connor
Journal:  Br J Vener Dis       Date:  1982-06

10.  Antibiotic susceptibilities and auxotypes of Neisseria gonorrhoeae strains from women with pelvic inflammatory disease or uncomplicated infections.

Authors:  M Jacques; P L Turgeon; J deRepentigny; L G Mathieu
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.